Promising Colloidal Rhenium Disulfide Nanosheets: Preparation and Applications for In Vivo Breast Cancer Therapy.

Szczegóły
Abstrakt

Tytuł:: Promising Colloidal Rhenium Disulfide Nanosheets: Preparation and Applications for In Vivo Breast Cancer Therapy.
Autorzy:: Song Y; College of Physics and Optoelectronic Engineering, Shenzhen Key Laboratory of Photonics and Biophotonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen 518060, China.
Yuan Y; College of Physics and Optoelectronic Engineering, Shenzhen Key Laboratory of Photonics and Biophotonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen 518060, China.; School of Electronic Engineering and Intelligentization, Dongguan University of Technology, Dongguan 523808, China.
Peng X; College of Physics and Optoelectronic Engineering, Shenzhen Key Laboratory of Photonics and Biophotonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen 518060, China.
Peng Z; College of Physics and Optoelectronic Engineering, Shenzhen Key Laboratory of Photonics and Biophotonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen 518060, China.
Liu H; College of Physics and Optoelectronic Engineering, Shenzhen Key Laboratory of Photonics and Biophotonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen 518060, China.
Zhou Y; College of Physics and Optoelectronic Engineering, Shenzhen Key Laboratory of Photonics and Biophotonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen 518060, China.
Zhang X; Department of Pharmacology, College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.
Zhou F; College of Physics and Optoelectronic Engineering, Shenzhen Key Laboratory of Photonics and Biophotonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen 518060, China.
Song J; College of Physics and Optoelectronic Engineering, Shenzhen Key Laboratory of Photonics and Biophotonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen 518060, China.
Qu J; College of Physics and Optoelectronic Engineering, Shenzhen Key Laboratory of Photonics and Biophotonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen 518060, China.
Źródło:: Nanomaterials (Basel, Switzerland) [Nanomaterials (Basel)] 2022 Jun 06; Vol. 12 (11). Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Basel, Switzerland : MDPI AG, [2011]-
References:: Chem Soc Rev. 2019 Apr 1;48(7):2053-2108. (PMID: 30259015)
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17561-6. (PMID: 23045683)
Small. 2017 Sep;13(36):. (PMID: 28737290)
ACS Appl Mater Interfaces. 2017 Aug 2;9(30):25098-25106. (PMID: 28671452)
CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338)
Eur J Pharm Biopharm. 2015 Jun;93:52-79. (PMID: 25813885)
Theranostics. 2016 Mar 21;6(6):762-72. (PMID: 27162548)
Anal Chem. 2017 Aug 1;89(15):8104-8111. (PMID: 28661125)
J Am Chem Soc. 2016 Mar 9;138(9):3152-60. (PMID: 26871001)
J Clin Lab Anal. 2020 Feb;34(2):e23063. (PMID: 31595567)
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W451-4. (PMID: 16845047)
J Am Chem Soc. 2008 Aug 20;130(33):10876-7. (PMID: 18661992)
Biomater Sci. 2018 May 29;6(6):1503-1516. (PMID: 29633765)
Nano Res. 2008;1(3):203-212. (PMID: 20216934)
Nat Commun. 2016 Sep 30;7:12967. (PMID: 27686999)
Small. 2020 Oct;16(43):e2004173. (PMID: 33006243)
Cancer Lett. 2004 Jun 25;209(2):171-6. (PMID: 15159019)
Adv Mater. 2014 Mar 26;26(12):1886-93. (PMID: 24375758)
Angew Chem Int Ed Engl. 2013 Jul 1;52(27):6926-9. (PMID: 23716349)
Curr Opin Pharmacol. 2010 Oct;10(5):543-50. (PMID: 20541466)
Biomark Med. 2021 Aug;15(12):951-963. (PMID: 34293926)
Breast Cancer Res. 2010;12(2):201. (PMID: 20346098)
Cancer Lett. 1996 Jan 2;98(2):169-73. (PMID: 8556705)
Nat Commun. 2014;5:3252. (PMID: 24500082)
J Biomed Opt. 2009 Mar-Apr;14(2):021009. (PMID: 19405722)
Nat Biotechnol. 2008 Apr;26(4):407-15. (PMID: 18392026)
Nano Lett. 2011 Jun 8;11(6):2560-6. (PMID: 21553924)
Adv Mater. 2013 Feb 6;25(5):777-82. (PMID: 23143782)
Nat Nanotechnol. 2008 Mar;3(3):145-50. (PMID: 18654486)
Front Cell Dev Biol. 2021 Jan 11;8:571948. (PMID: 33505957)
Nucleic Acids Res. 2002 Feb 15;30(4):e15. (PMID: 11842121)
ACS Appl Mater Interfaces. 2016 Aug 17;8(32):20900-8. (PMID: 27467718)
Nat Nanotechnol. 2011 Oct 23;6(12):815-23. (PMID: 22020122)
J Phys Chem C Nanomater Interfaces. 2007 Sep;111(9):3636-3641. (PMID: 19011696)
J Nanobiotechnology. 2021 May 13;19(1):137. (PMID: 33985525)
Small. 2018 Apr;14(14):e1703789. (PMID: 29468828)
Adv Mater. 2014 Jun 4;26(21):3433-40. (PMID: 24677423)
Acc Chem Res. 2008 Dec;41(12):1578-86. (PMID: 18447366)
ACS Nano. 2011 Dec 27;5(12):9761-71. (PMID: 22059851)
Angew Chem Int Ed Engl. 2017 Sep 18;56(39):11896-11900. (PMID: 28640986)
Bioinformatics. 2010 Jan 1;26(1):136-8. (PMID: 19855105)
Biomaterials. 2013 Dec;34(37):9584-92. (PMID: 24044996)
Int J Mol Sci. 2016 Apr 27;17(5):. (PMID: 27128908)
Angew Chem Int Ed Engl. 2015 Sep 21;54(39):11526-30. (PMID: 26296530)
J Antimicrob Chemother. 2017 Jun 1;72(6):1581-1588. (PMID: 28186558)
Nano Lett. 2010 Sep 8;10(9):3318-23. (PMID: 20684528)
Int J Nanomedicine. 2014 Jan 15;9:467-83. (PMID: 24531078)
ACS Nano. 2015 Jan 27;9(1):363-70. (PMID: 25514177)
Chem Soc Rev. 2015 May 7;44(9):2681-701. (PMID: 25519856)
RNA Biol. 2009 Nov-Dec;6(5):575-83. (PMID: 19875930)
Biomaterials. 2012 Mar;33(7):2206-14. (PMID: 22169821)
Nat Genet. 2019 Feb;51(2):308-318. (PMID: 30643250)
Nanoscale. 2014 Aug 21;6(16):9494-530. (PMID: 25030381)
ACS Nano. 2015 Jan 27;9(1):950-60. (PMID: 25562533)
Grant Information:: (62075137/31771584/61620106016/61835009/62175161) National Natural Science Foundation of China; 2020A1515010377 Guangdong Basic and Applied Basic Research Foundation
Contributed Indexing:: Keywords: PEG-ReS2 nanosheets; in vivo photothermal therapy; miRNA expression analysis; photothermal conversion efficiency; therapeutic outcomes
Entry Date(s):: Date Created: 20220610 Latest Revision: 20220716
Update Code:: 20240105
PubMed Central ID:: PMC9182237
DOI:: 10.3390/nano12111937
PMID:: 35683791
: Czasopismo naukowe

Full Text Finder

Photothermal therapy (PTT) has become an important therapeutic strategy in the treatment of cancer. However, exploring novel photothermal nanomaterials with satisfactory biocompatibility, high photothermal conversion efficiency, and efficient theranostic outcomes, remains a major challenge for satisfying clinical application. In this study, poly-ethylene glycol modified rhenium disulfide (PEG-ReS 2 ) nanosheets are constructed by a simple-liquid phase exfoliation method. The PEG-ReS 2 nanosheets were demonstrated to have good solubility, good biocompatibility, low toxicity, and strong capability of accumulating near-infrared (NIR) photons. Under 808 nm laser irradiation, the PEG-ReS 2 nanosheets were found to have an excellent photothermal conversion efficiency (PTCE) of 42%. Moreover, the PEG-ReS 2 nanosheets were demonstrated to be ideal photothermal transduction agents (PTAs), which promoted rapid cancer cell death in vitro and efficiently ablated tumors in vivo. Interestingly, the potential utility of up-regulation or down-regulation of miRNAs was proposed to evaluate the therapeutic outcomes of PEG-ReS 2 nanosheets. The expression levels of a set of miRNAs in tumor-bearing mice were restored to normal levels after PTT therapy with PEG-ReS 2 nanosheets. Both down-regulation miRNAs (miR-125a-5p, miR-34a-5p, miR-132-3p, and miR-148b-3p) and up-regulation miRNAs (miR-133a-3p, miR-200c-5p, miR-9-3p, and miR-150-3p) were suggested to be important clinical biomarkers for evaluating therapeutic outcomes of breast cancer-related PTT. This work highlights the great significance of PEG-ReS 2 nanosheets as therapeutic nanoagents for cancer therapy.

Informacja